Valuation: BioGaia AB

Market Cap 11.69B 1.21B 1.06B 985M 904M 1.7B 116B 1.72B 4.57B 57.08B 4.53B 4.43B 197B P/E 2026 *
30.2x
P/E 2027 * 24.6x
Enterprise Value 11.03B 1.14B 999M 929M 852M 1.6B 109B 1.63B 4.31B 53.83B 4.27B 4.18B 186B EV / Sales 2026 *
6.61x
EV / Sales 2027 * 5.89x
Free-Float
80.82%
Yield 2026 *
2.55%
Yield 2027 * 2.77%
1 day-2.20%
1 week-7.37%
Current month-1.11%
1 month-3.34%
3 months-1.70%
6 months+2.39%
Current year+8.85%
1 week 114.5
Extreme 114.5
124.9
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 46.8
Extreme 46.8
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Director

582 0.0006%
12/30/25 A Buy

General Counsel

390 0.0004%
12/5/25 A Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-7.37%+15.72%+13.33% 1.22B
+0.63%-3.06%+16.18%-9.78% 66.32B
+1.23%+2.80%+37.51%+202.14% 52.6B
+10.08%+51.80%+51.80%+51.80% 43.27B
-1.32%-7.38%-57.63%-57.10% 38.64B
+0.78%-1.84%+52.49%-27.01% 29.62B
+0.84%+0.36%+66.93%+85.42% 23.31B
-5.17%-12.54%+58.98%-56.04% 22.62B
-1.21%+1.12%+1.98%+170.93% 20.22B
-0.22%-0.95%+61.97%+123.78% 16.29B
Average +0.94%-0.99%+30.59%+49.75% 31.41B
Weighted average by Cap. +1.66%-0.40%+27.31%+49.12%

Financials

2026 *2027 *
Net sales 1.67B 172M 151M 141M 129M 242M 16.58B 246M 652M 8.15B 646M 632M 28.18B 1.88B 193M 170M 158M 145M 272M 18.63B 277M 733M 9.16B 726M 711M 31.67B
Net income 387M 39.9M 35.04M 32.59M 29.91M 56.19M 3.84B 57.06M 151M 1.89B 150M 147M 6.53B 474M 48.87M 42.92M 39.92M 36.63M 68.82M 4.71B 69.88M 185M 2.31B 183M 180M 8B
Net Debt -667M -68.77M -60.4M -56.17M -51.54M -96.85M -6.62B -98.34M -261M -3.26B -258M -253M -11.26B -646M -66.55M -58.45M -54.36M -49.88M -93.72M -6.41B -95.17M -252M -3.15B -250M -244M -10.89B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
24/07/26 SEK 115.60 -2.20% 93,266
23/07/26 SEK 118.20 +0.77% 92,151
22/07/26 SEK 117.30 -2.57% 119,418
21/07/26 SEK 120.40 +1.18% 265,484
20/07/26 SEK 119.00 -4.65% 276,178
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
115.60SEK
Average target price
152.50SEK
Spread / Average Target
+31.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock